1461086669-0019f136-f198-4790-80a0-02770fe3864e

1. An apparatus comprising: a chassis including a first electronic circuit board with a first connector, chassis flex circuitry with a disengageable contacts, a controller in communication with the chassis flex circuitry, and a power supply in communication with the controller and the first electronic circuit board; and a cassette selectively securable to the chassis, the cassette including a second electronic circuit board with a second connector, and a cassette handle with cassette flex circuitry that includes a switch and disengageable contacts, wherein securing the cassette to the chassis positions the disengageable contacts of the cassette flex circuitry in engagement with the disengageable contacts of the chassis flex circuitry to form a circuit and positions the first connector in electronic communication with the second connector, and wherein the circuit allows the controller to detect the condition of the switch; and a switch trigger on the cassette handle to actuate the switch; and wherein the switch trigger selectively locks or unlocks the cassette to the chassis.
2. The apparatus of claim 1, further comprising:
a spring to maintain the switch in a specified position.
3. The apparatus of claim 1, wherein the chassis further comprises an access cover that selectively completes the chassis flex circuitry.
4. The apparatus of claim 1, wherein the disengageable contact is comprised of a metal tab.
5. The apparatus of claim 1, further comprising:
a spring biasing the switch trigger to actuate the switch.
6. The apparatus of claim 1, wherein the chassis flex circuitry is disposed upon the first electronic circuit board.
7. The apparatus of claim 1, wherein the switch is a surface mount switch.
8. The apparatus of claim 1, further comprising an indicator light emitting diode (LED) controlled by the controller for indicating a quiescent state of the second electronic circuit board.
9. The apparatus of claim 4, wherein the metal tab includes gold contacts.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

We claim as our invention:

1. A subcutaneous cavity marking device comprising:
(a) at least one filler body comprising a resilient bioabsorbable material, and
(b) at least one marker.
2. The device of claim 1 wherein the at least one marker comprises a non-bioabsorbable material.
3. The device of claim 2 wherein the marker comprises a material selected from the group consisting of platinum, iridium, nickel, tungsten, tantalum, gold, silver, rhodium, titanium, alloys thereof, and stainless steel.
4. The device of claim 1 wherein the at least one marker comprises a second bioabsorbable material.
5. The device of claim 4 wherein the second bioabsorbable material comprises a polymer having a radiopaque additive.
6. The device of claim 5 wherein the radiopaque additive is selected from the group consisting of barium-containing compounds, bismuth-containing compounds, powdered tantalum, powdered tungsten, barium carbonate, bismuth oxide, and barium sulfate.
7. The device of claim 1 wherein the at least one marker is radiopaque.
8. The device of claim 1 wherein the at least one body is radiopaque.
9. The device of claim 1 wherein the at least one marker is echogenic.
10. The device of claim 1 wherein the at least one body is echogenic.
11. The device of claim 1 wherein the at least one marker is mammographic.
12. The device of claim 1 wherein the at least one body is mammographic.
13. The device of claim 1 wherein the at least one body is palpable.
14. The device of claim 1 wherein the marker is located within an interior of the at least one body.
15. The device of claim 1 wherein the marker is substantially located within a geometric center of the at least one body.
16. The device of claim 1 additionally comprising a pain killing substance.
17. The device of claim 1 additionally comprising a hemostatic substance.
18. The device of claim 1 wherein the bioabsorbable material is selected from the group consisting of collagen, regenerated cellulose, synthetic polymers and synthetic proteins.
19. The device of claim 1 wherein the marker has a form of a sphere.
20. The device of claim 19 wherein the sphere is hollow.
21. The device of claim 1 wherein the marker has a form of a band.
22. The device of claim 1 wherein the marker comprises a suture.
23. The device of claim 1 wherein the marker comprises a wire.
24. The device of claim 1 wherein the marker has a distinguishing mark.
25. The device of claim 1 wherein the marker is fixedly attached to the at least one body.
26. The device of claim 25 wherein the marker is woven to the at least one body.
27. The device of claim 1 wherein the marker is radioactive.
28. The device of claim 1 wherein the at least one body is radioactive.
29. The device of claim 1 wherein the at least one body is substantially spherical.
30. The device of claim 1 wherein the at least one body is substantially cylindrical.
31. The device of claim 1 wherein the at least one body is has a substantially irregular shape.
32. The device of claim 1 wherein the at least one body is a biocompatible gel.
33. The device of claim 1 wherein the at least one body comprises a plurality of pores.
34. The device of claim 1 wherein the pores are configured to promote tissue growth in a preferred orientation.
35. The device of claim 1 wherein the at least one filler body additionally comprises a bio-compatible liquid.
36. A subcutaneous cavity marking device comprising a plurality of resilient bioabsorbable filler bodies, at least two of which are connected by at least one marker.
37. The device of claim 36 wherein the at least one marker is suspended through the interior of at least one of the plurality of filler bodies.
38. The device of claim 36 wherein the at least one marker is attached substantially to an outer perimeter of at least one of the plurality of bodies.
39. A method of marking a tissue cavity comprising the steps of:
(a) suspending a marker within at least one filler body of resilient bioabsorbable material, and
(b) inserting the at least one filler body into the cavity.
40. The method of claim 39 wherein the step of inserting the at least one filler body into the cavity is performed percutaneously.
41. The method of claim 40 wherein the at least one filler body additionally comprises a hemostatic substance.
42. The method of claim 40 wherein the at least one filler body additionally comprises a pain-killing substance.
43. The method of claim 40 wherein the marker is radiopaque.
44. The method of claim 40 wherein the marker is echogenic.
45. The method of claim 40 wherein the at least one body is radiopaque.
46. The method of claim 40 wherein the at least one body is echogenic.
47. The method of claim 40 wherein the marker is fixedly attached to the at least one body.
48. The method of claim 39 wherein the step of inserting the at least one filler body into the cavity is performed surgically.
49. The method of claim 39 wherein the step of inserting the at least one filler body of resilient bioabsorbable material into the cavity is performed prior to the step of suspending the marker within the filler body.
50. A method of marking a tissue cavity having a margin in a mammalian body, comprising:
(a) subcutaneously accessing the cavity via a delivery device,
(b) deploying a remotely detectable marker having a predetermined shape through the delivery device into the cavity,
wherein upon delivery into the cavity the marker assumes a predetermined three-dimensional configuration so to (1) substantially fill the cavity, (2) mark the cavity margin, and (3) indicate the orientation of the marker inside the cavity.
51. The method of claim 50 wherein the marker is bioabsorbable.
52. The method of claim 50 wherein the marker is radiopaque.
53. The method of claim 50 wherein the marker is echogenic.
54. The method of claim 50 wherein the marker comprises a wire.
55. The method of claim 50 wherein the marker comprises a material selected from the group consisting of platinum, iridium, nickel, tungsten, tantalum, gold, silver, rhodium, titanium, alloys thereof, and stainless steel.
56. The method of claim 50 wherein the marker is capable of emitting radioactive energy.
57. The method of claim 50 wherein the marker is a helical coil.
58. The method of claim 50 wherein the marker defines a volume having a substantially spherical shape when the marker is deployed inside the cavity.
59. The method of claim 50 wherein the marker defines a volume comprising a substantially cylindrical shape when the marker is deployed inside the cavity.
60. The method of claim 50 wherein the marker defines a volume comprising a random shape when the marker is deployed inside the cavity.
61. The method of claim 50 wherein the wire comprises a shape memory material.
62. The method of claim 50 further comprising the step of introducing a biocompatible liquid in the marker prior to the step of deploying the marker.
63. The method of claim 62 wherein the delivery device uses a hydraulic force to deploy the marker.
64. The method of claim 50 further comprising the step of introducing a biocompatible liquid in the marker subsequent to the step of deploying the marker.
65. The method of claim 64 wherein the bio-compatible liquid is introduced to the marker via the delivery device.
66. A method of marking a tissue cavity comprising the steps of:
(a) inserting the at least one filler body into the cavity, and
(b) suspending a marker within at least one filler body of resilient bioabsorbable material, and